M O17 (Oxybutynin Chloride Extended Release 15 mg)
Pill with imprint M O17 is Gray, Round and has been identified as Oxybutynin Chloride Extended Release 15 mg. It is supplied by Mylan Pharmaceuticals Inc..
Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; dysuria; neurogenic detrusor overactivity and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M O17
Oxybutynin Chloride Extended Release
- Imprint
- M O17
- Strength
- 15 mg
- Color
- Gray
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-6015 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 54868-5743 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related Images for "M O17"
More about oxybutynin
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 398 Reviews
- Drug class: urinary antispasmodics
Patient resources
- Drug Information
- Oxybutynin transdermal
- Oxybutynin (Advanced Reading)
- Oxybutynin Transdermal (Advanced Reading)
- Oxybutynin Extended-Release Tablets
- Other brands
- Ditropan, Ditropan XL, Oxytrol, Gelnique, Anturol
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.